v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock and Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Common stock, beginning balance (in shares) at Dec. 31, 2024   64,043,799    
Stockholders' equity (deficit), beginning balance at Dec. 31, 2024 $ 365,207 $ 1,552,714 $ (1,186,672) $ (835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   980,857    
Vesting of restricted stock units and restricted shares 0      
Issuance of common stock related to acquisition (in shares)   5,560,583    
Issuance of common stock related to acquisition 31,584 $ 31,584    
Repurchase of common stock (in shares)   (1,103,601)    
Repurchase of common stock (5,000) $ (5,000)    
Stock-based compensation 7,787 $ 7,787    
Net loss (23,742)   (23,742)  
Other comprehensive income (loss) 975     975
Common stock, ending balance (in shares) at Mar. 31, 2025   69,481,638    
Stockholders' equity (deficit), ending balance at Mar. 31, 2025 $ 376,811 $ 1,587,085 (1,210,414) 140
Common stock, beginning balance (in shares) at Dec. 31, 2025 72,027,332 72,027,332    
Stockholders' equity (deficit), beginning balance at Dec. 31, 2025 $ 245,780 $ 1,608,840 (1,364,646) 1,586
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   1,721,334    
Vesting of restricted stock units and restricted shares 0      
Stock-based compensation 3,968 $ 3,968    
Net loss (111,026)   (111,026)  
Other comprehensive income (loss) $ (577)     (577)
Common stock, ending balance (in shares) at Mar. 31, 2026 73,748,666 73,748,666    
Stockholders' equity (deficit), ending balance at Mar. 31, 2026 $ 138,145 $ 1,612,808 $ (1,475,672) $ 1,009